SCENESSE
LIVE

Serial Number

79229902

Owner

Clinuvel Pharmaceuticals Limited

Attorney

Michelle P. Ciotola

Filing Date

Feb 13, 2018

Add to watchlist:

No watchlists yet
View on USPTO

SCENESSE Trademark

Serial Number: 79229902 • Registration: 5724241

SCENESSE is a trademark filed by Clinuvel Pharmaceuticals Limited on February 13, 2018. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Clinuvel Pharmaceuticals Limited (4 trademarks)

Level 11, 330 Collins Street

Entity Type: 98

Trademark Details

Filing Date

February 13, 2018

Registration Date

April 16, 2019

Published for Opposition

January 29, 2019

Goods & Services

[ Cosmetic preparations for skin care, based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide; non-medicated sun tanning preparations based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin, namely, cosmetics for tanning the skin based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, and preparations for tanning without sunlight based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide ]

Pharmaceutical preparations, based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, for skin care and for treating skin and skin relating conditions and disorders; medicated sun tanning preparations for pharmaceutical purposes, based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide; chemical and biological preparations, substances, reagents and compounds, namely, drug delivery agents consisting of compounds that facilitate the delivery of pharmaceuticals which are based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, and pharmaceutical preparations based on analogues of melanocyte-stimulating hormone (MSH), in particular afamelanotide, for use in dermatology, for skin care, for the treatment of skin disorders, for the protection of the dermis and epidermis used in the manufacture, delivery and storage of pharmaceuticals, drugs and diagnostic preparations

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 14, 2026 INPR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 18, 2025 ADCH
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jul 14, 2025 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Jul 14, 2025 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 14, 2025 APRE
TEAS SECTION 71 & 15 RECEIVED
Apr 16, 2025 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 16, 2024 REM3
INTERNATIONAL REGISTRATION RENEWED
Jul 2, 2020 RNWL
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 14, 2019 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 13, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 8, 2019 FICS
FINAL DISPOSITION PROCESSED
Aug 8, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 16, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 16, 2019 R.PR
NOTIFICATION PROCESSED BY IB
Mar 1, 2019 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 29, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 29, 2019 PUBO
TOTAL INVALIDATION PROCESSED BY THE IB
Jan 11, 2019 INNT
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 9, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 9, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 9, 2019 NONP
ASSIGNED TO LIE
Dec 26, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 3, 2018 TROA
REFUSAL PROCESSED BY IB
Jun 29, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 7, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jun 7, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 1, 2018 RFCR
NON-FINAL ACTION WRITTEN
May 31, 2018 CNRT
ASSIGNED TO EXAMINER
May 29, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 14, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 9, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Apr 5, 2018 SDRC